The Brazilian variant of human immunodeficiency virus type 1 (HIV-1) subtype B, (serotype B"-GWGR), has a tryptophan replacing the proline in position 328 the HIV-1 envelope. A longer median time period from infection to acquired immunodeficiency syndrome (AIDS) for serotype B (B"-GWGR) infected subjects compared to the B-GPGR
month, for B-GPGR and B"-GWGR patients, respectively (p = 0.53). Neither group presented any AIDS defining events during the study, according to Center for Diseases Control criteria. Although the sample size is small, these results may indicate that differences in the pathogenicity of the 2 HIV-1 B serotypes which co-circulate in Brazil may be correlated to the avidity of anti-V3 antibodies.Key words: human immunodeficiency virus type 1 (HIV-1) -Brazilian HIV-1 variant -V3 serotyping -antibody aviditySão Paulo -BrazilThe Brazilian variant of human immunodeficiency virus type 1 (HIV-1) subtype B, named serotype B"-GWGR, has a unique signature in the tip of the V3 loop, with tryptophan replacing proline in position 328 in the HIV-1 envelope (Louwagie et al. 1994). Molecular typing and V3 serology approaches showed that this variant accounts for almost half of the subtype B infection in Brazil (Louwagie et al. 1994, Casseb et al. 1998. Recently, Santoro-Lopes et al. (2000) reported a longer median time to acquired immunodeficiency syndrome (AIDS) among serotype B (B"-GWGR) infected subjects compared to the B-GPGR US/European strain. A cohort study in São Paulo, we also found a 2-fold decreased risk of AIDS development among asymptomatic, untreated patients with B"-GWGR serology versus B-GPGR serology (Casseb et al. 2002). The possible difference in pathogenesis has still to be explained. To address this point, we have used a previously described V3 serologic assay to identify the Brazilian variant and to assess the avidity of V3 antibodies (Hendry el al. 1996, Casseb et al. 1998. Biotinylated peptides based on the V3 loop consensus sequence from subtype B (Consensus B: N T R K S I H I G P G R A F Y), and 1 synthetic peptide based on the consensus sequence of the Brazilian variant subtype B strain (Strain BR1: N T R K S I H I G W G R A) were captured onto avidin-coated 96 well plates. Serial 4-fold dilutions of test sera were added to duplicate plates, 1 of which was washed 5 times with a hiperosmolar (8 M) urea solution, and the other plate with 5 washings in PBS. Peroxidase-labeled anti-human IgG was added, incubated for 1 h, and the reaction was developed with the substrate hydrogen peroxide and the tetrametilbenzidine chromogen. The plates were read at 450 nm and the end-point titers were interpolated from the linear portion of the titration curve yielding a mean absorbance of 0.5 optical density units. The high avidity anti-V3 antibodies index (HAAV3 index) was calculated using the dilution end-point in the 8 M ureawashed plate divided by the dilution end-point in the PBSwashed plate. Antibodies with HAAV3 index greater than 50% were considered to possess higher affinity. One serum sample...